Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Myriad Genetics Inc
XMUN:MYD
Myriad Genetics Inc
XMUN:MYD
Price:
5.868
EUR
5.46%
Market Closed
Market Cap:
€527.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Myriad Genetics Inc
XMUN:MYD
|
US |
|
C
|
China Rare Earth Holdings Ltd
XMUN:RAE
|
CN |
|
E
|
Eclipse Metals Ltd
F:9EU
|
AU |
|
HAL Trust
AEX:HAL
|
NL |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
S
|
Sumitomo Realty & Development Co Ltd
OTC:SURDF
|
JP |
|
E
|
EQT Corp
SWB:EQ6
|
US |
|
T
|
Tutor Perini Corp
SWB:PE2
|
US |
|
W
|
Wattanapat Hospital Trang PCL
SET:WPH
|
TH |
|
A
|
Adidas AG
XMUN:ADS
|
DE |
|
R
|
Rio Tinto PLC
OTC:RTPPF
|
UK |
|
B
|
Burckhardt Compression Holding AG
XMUN:B5H
|
CH |
|
C
|
Captor Capital Corp
CNSX:CPTR
|
CA |
|
C
|
China Pacific Insurance Group Co Ltd
OTC:CHPXF
|
CN |
|
International Container Terminal Services Inc
F:P9I
|
PH |
|
Singapore Post Ltd
SGX:S08
|
SG |
|
Tlou Energy Ltd
F:55L
|
AU |
Wall St Price Targets
MYD Price Forecast
Based on 9 analysts
Based on 9 analysts
-28% Downside
from
€5.868
today
Myriad Genetics Inc (MYD)’s 12-month stock price forecast through October 2027 has a consensus target of €4.241, implying 28% downside. The forecast is based on price targets from 9 Wall Street analysts.
MYD Analyst Rating
No ratings yet
No ratings yet
Myriad Genetics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
4.241
EUR
4.241
EUR
According to Wall Street analysts, the average 1-year price target for MYD is 4.241 EUR with a low forecast of 2.282 EUR and a high forecast of 7.593 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
4%
4%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 4%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
4%
4%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 4%.